Company Profiles

driven by the PitchBook Platform

Ablexis

Description

Developer of a platform for human therapeutic antibody drug discovery. The company offers AlivaMab Mouse, a transgenic mouse platform that provides the foundation for the discovery and development of human therapeutic antibodies to treat human diseases.

2009

Founded

PRIVATE

Status

Series A

Latest Deal Type

$12M

Latest Deal Amount

$12M

Total Amount Raised

3

Investors

Description

Developer of a platform for human therapeutic antibody drug discovery. The company offers AlivaMab Mouse, a transgenic mouse platform that provides the foundation for the discovery and development of human therapeutic antibodies to treat human diseases.

Website:

www.ablexis.com

Formerly Known As

Aliva Pharmaceuticals

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

409 Illinois Street San Francisco, CA 94158United States +1 (415) 967-1220
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Ablexis's full profile, request a free trial.

    Ablexis Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Ablexis Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    California Technology VenturesVenture CapitalMinority000 0000000 0000
    Pfizer Venture InvestmentsCorporate Venture CapitalMinority000 0000000 0000
    Third Rock VenturesVenture CapitalMinority000 0000000 0000
    California Technology Ventures Venture Capital
    Pfizer Venture Investments Corporate Venture Capital
    Third Rock Ventures Venture Capital

    Ablexis Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Larry Green Ph.DCo-Founder, Chief Executive Officer & Board Member
    John Lippincott Ph.DConsultant
    Hiroaki Shizuya Ph.DCo-Founder
    Sean Stevens Ph.DVice President, Research
    Larry Green Ph.D Co-Founder, Chief Executive Officer & Board Member
    John Lippincott Ph.D Consultant
    Hiroaki Shizuya Ph.D Co-Founder
    Sean Stevens Ph.D Vice President, Research

    Ablexis Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Barbara Dalton Ph.DPfizer Venture InvestmentsBoard Observer000 0000
    Cary Pfeffer MDThird Rock VenturesBoard Member000 0000
    Jennifer GoldsteinPfizer Venture InvestmentsBoard Observer000 0000
    Larry Green Ph.DAblexisCo-Founder, Chief Executive Officer & Board Member000 0000
    Lou Tartaglia Ph.DThird Rock VenturesBoard Member000 0000
    Barbara Dalton Ph.D Board Observer Pfizer Venture Investments
    Cary Pfeffer MD Board Member Third Rock Ventures
    Jennifer Goldstein Board Observer Pfizer Venture Investments
    Larry Green Ph.D Co-Founder, Chief Executive Officer & Board Member Ablexis
    Lou Tartaglia Ph.D Board Member Third Rock Ventures
    Request full access to PitchBook